Literature DB >> 30396904

Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes.

Clemens Wittenbecher1,2, Meriem Ouni2,3, Olga Kuxhaus1,2, Markus Jähnert2,3, Pascal Gottmann2,3, Andrea Teichmann2,3, Karina Meidtner1, Jennifer Kriebel2,4, Harald Grallert2,4, Tobias Pischon5,6,7,8, Heiner Boeing9, Matthias B Schulze1,2,10, Annette Schürmann11,3.   

Abstract

Recent studies suggest that insulin-like growth factor binding protein 2 (IGFBP-2) may protect against type 2 diabetes, but population-based human studies are scarce. We aimed to investigate the prospective association of circulating IGFBP-2 concentrations and of differential methylation in the IGFBP-2 gene with type 2 diabetes risk.
© 2018 by the American Diabetes Association.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30396904     DOI： 10.2337/db18-0620

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


  16 in total

1.  Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women.

Authors:  Amy E Mendham; Lisa K Micklesfield; Fredrik Karpe; Andre Pascal Kengne; Tinashe Chikowore; Clement N Kufe; Maphoko Masemola; Nigel J Crowther; Shane A Norris; Tommy Olsson; Sölve Elmståhl; Tove Fall; Lars Lind; Julia H Goedecke
Journal:  Diabetologia       Date:  2022-09-17       Impact factor: 10.460

Review 2.  Trends in insulin resistance: insights into mechanisms and therapeutic strategy.

Authors:  Mengwei Li; Xiaowei Chi; Ying Wang; Sarra Setrerrahmane; Wenwei Xie; Hanmei Xu
Journal:  Signal Transduct Target Ther       Date:  2022-07-06

Review 3.  The Roles of Insulin-Like Growth Factor Binding Protein Family in Development and Diseases.

Authors:  Fei Song; Xiao-Xia Zhou; Yu Hu; Gang Li; Yan Wang
Journal:  Adv Ther       Date:  2020-12-17       Impact factor: 3.845

Review 4.  Epigenetic contribution to obesity.

Authors:  Meriem Ouni; Annette Schürmann
Journal:  Mamm Genome       Date:  2020-04-11       Impact factor: 2.957

5.  Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes.

Authors:  Melissa K Thomas; Amir Nikooienejad; Ross Bray; Xuewei Cui; Jonathan Wilson; Kevin Duffin; Zvonko Milicevic; Axel Haupt; Deborah A Robins
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

Review 6.  Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance.

Authors:  Hatim Boughanem; Elena M Yubero-Serrano; José López-Miranda; Francisco J Tinahones; Manuel Macias-Gonzalez
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

Review 7.  Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.

Authors:  Oriol Juanola; Sebastián Martínez-López; Rubén Francés; Isabel Gómez-Hurtado
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

8.  Physiological Disturbance in Fatty Liver Energy Metabolism Converges on IGFBP2 Abundance and Regulation in Mice and Men.

Authors:  Pia Fahlbusch; Birgit Knebel; Tina Hörbelt; David Monteiro Barbosa; Aleksandra Nikolic; Sylvia Jacob; Hadi Al-Hasani; Frederique Van de Velde; Yves Van Nieuwenhove; Dirk Müller-Wieland; Bruno Lapauw; D Margriet Ouwens; Jorg Kotzka
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

9.  Circulating IGFBP-2: a novel biomarker for incident dementia.

Authors:  Emer R McGrath; Jayandra J Himali; Daniel Levy; Sarah C Conner; Charles S DeCarli; Matthew P Pase; Paul Courchesne; Claudia L Satizabal; Ramachandran S Vasan; Alexa S Beiser; Sudha Seshadri
Journal:  Ann Clin Transl Neurol       Date:  2019-08-02       Impact factor: 4.511

10.  Epigenetic Changes in Islets of Langerhans Preceding the Onset of Diabetes.

Authors:  Meriem Ouni; Sophie Saussenthaler; Fabian Eichelmann; Markus Jähnert; Mandy Stadion; Clemens Wittenbecher; Tina Rönn; Lisa Zellner; Pascal Gottmann; Charlotte Ling; Matthias B Schulze; Annette Schürmann
Journal:  Diabetes       Date:  2020-08-17       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.